Renaissance Technologies - ZYNERBA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$772
+243.1%
605,700
-12.2%
0.00%
Q2 2023$225
-8.2%
689,713
+21.1%
0.00%
Q1 2023$245
-44.9%
569,700
-32.2%
0.00%
-100.0%
Q4 2022$445
-99.9%
840,500
-24.3%
0.00%0.0%
Q3 2022$813,000
-3.2%
1,110,035
+50.7%
0.00%0.0%
Q2 2022$840,000
+24.8%
736,600
+124.3%
0.00%0.0%
Q1 2022$673,000
-39.9%
328,400
-15.4%
0.00%0.0%
Q4 2021$1,119,000
-26.1%
388,385
+8.8%
0.00%
-50.0%
Q3 2021$1,514,000
+218.7%
356,982
+147.9%
0.00%
+100.0%
Q4 2020$475,000
+666.1%
144,000
+674.2%
0.00%
Q3 2020$62,000
-88.7%
18,600
-89.9%
0.00%
-100.0%
Q4 2018$547,000184,3000.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Ground Swell Capital, LLC 25,445$19,0000.05%
ETF MANAGERS GROUP, LLC 2,258,970$1,654,0000.05%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 116,780$85,0000.02%
GSA CAPITAL PARTNERS LLP 131,036$96,0000.01%
Bernardo Wealth Planning LLC 30,469$20,0000.01%
PCG Wealth Advisors, LLC 15,200$12,0000.00%
Penserra Capital Management LLC 212,298$155,0000.00%
ZEKE CAPITAL ADVISORS, LLC 49,700$36,0000.00%
King Wealth Management Group 16,000$12,0000.00%
Vident Investment Advisory, LLC 105,398$77,0000.00%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders